Idiopathic pulmonary fibrosis (IPF) results from repeated microscopic injuries to the lung’s air sacs, combined with an abnormal healing response that produces excessive scar tissue instead of healthy lung tissue. The word “idiopathic” means no single identifiable cause has been found, but researchers have pinpointed several factors that work together to trigger and sustain the disease. Most people are diagnosed around age 67 to 70, and roughly 70% of cases occur in men.
How Lung Scarring Actually Develops
Healthy lungs repair minor damage all the time. In IPF, that repair process goes wrong. When the thin cells lining the air sacs (alveoli) are injured repeatedly, the body sends repair signals that activate cells called fibroblasts. Normally, fibroblasts lay down a small amount of collagen to patch the wound, then stop. In IPF, the communication between the damaged lining cells and the fibroblasts becomes deeply dysfunctional. The fibroblasts multiply excessively and transform into more aggressive cells called myofibroblasts, which deposit large amounts of collagen and other structural proteins that stiffen and thicken the lung tissue.
These clusters of overactive fibroblasts, called fibroblast foci, are the hallmark feature of IPF when lung tissue is examined under a microscope. They sit just beneath the damaged lining of the air sacs and are considered the advancing front of the scarring process. Over time, the buildup of dense, cross-linked scar tissue makes the lungs increasingly rigid, preventing oxygen from passing efficiently into the bloodstream.
Genetic Factors
Genetics play a significant role in who develops IPF. The most important common genetic variant sits near a gene called MUC5B, which is involved in producing mucus in the airways. People carrying one or two copies of this variant face 6 to 20 times the risk of developing IPF compared to people without it. At least 15 other common gene variants have been linked to IPF susceptibility, though each contributes a smaller amount of risk.
In families where multiple members develop pulmonary fibrosis (familial cases), the genetic picture is different. About 20 to 30% of these families carry rare mutations in genes responsible for maintaining telomeres, the protective caps on the ends of chromosomes. When these genes are faulty, telomeres shorten prematurely, which accelerates the aging of lung cells and may lead to more rapid disease progression. Another 1 to 3% of familial cases involve mutations in genes related to surfactant, the slippery coating that keeps air sacs from collapsing. In most familial cases, carrying just one copy of the mutation is enough to increase risk.
Having a genetic predisposition doesn’t guarantee you’ll develop IPF. These variants are common enough that 5 to 10% of healthy people carry them without ever getting the disease. Instead, genetics set the stage, and other factors push the process forward.
Aging and Cellular Wear
IPF is fundamentally a disease of aging. The average age at diagnosis is in the late 60s, and the disease shares several biological hallmarks with the aging process itself: shortened telomeres, accumulation of senescent (worn-out) cells, mitochondrial dysfunction, and genomic instability. Senescent lung cells don’t just stop working. They release inflammatory signals that push neighboring cells toward the same worn-out state and stimulate fibroblasts to produce excess scar tissue.
Environmental exposures can accelerate this cellular aging. Tobacco smoke and chronic ozone exposure generate reactive oxygen species that damage DNA and shorten telomeres. Pollutants like lead, traffic-related air pollution, and carbon black have also been linked to telomere shortening. Over decades, these accumulated insults erode the lung’s ability to repair itself properly, edging cells closer to an irreversible breakdown in function.
Smoking
Cigarette smoking is one of the most well-established environmental risk factors for IPF. A large nationwide population-based study found that current smokers had a 66% higher risk of developing IPF compared to people who had never smoked. Former smokers still had a 42% higher risk, though less than current smokers. Current smokers also had a 17% higher risk than former smokers, suggesting that quitting does reduce some of the excess risk, even if it doesn’t eliminate it entirely.
Smoking damages the delicate lining of the air sacs and triggers chronic low-grade inflammation, both of which feed the cycle of injury and abnormal repair that drives IPF.
Occupational and Environmental Exposures
Certain workplace exposures have been linked to increased IPF risk, particularly inhaling metal dust and wood dust over long periods. Research has found that men exposed to birch dust or hardwood dust had roughly 2.7 times the risk of developing IPF compared to unexposed individuals. Bird exposure (from keeping birds or working around them) has also been associated with a slightly elevated risk in men.
These exposures likely cause repeated microscopic injuries to the lung lining, the same type of damage that initiates the fibrotic cascade. The risk appears to depend on the duration, dose, and frequency of exposure, as well as the specific type of dust or particle involved.
Chronic Viral Infections
Persistent viral infections appear to significantly raise IPF risk. A meta-analysis found that Epstein-Barr virus (EBV), the virus best known for causing mono, was associated with nearly a 10-fold increase in IPF risk. Human herpesvirus 8 carried a roughly 9-fold increase. Cytomegalovirus (CMV) and human herpesvirus 7 each roughly doubled to tripled the risk.
The key distinction is that chronic or latent infections, not acute ones, seem to drive the association. EBV-infected cells in the lung lining may trigger the production of growth factors that promote the transition of epithelial cells into scar-producing cells. These viruses don’t cause IPF on their own, but in a genetically susceptible person with aging lungs, a persistent viral infection may provide the ongoing irritation that keeps the scarring process active.
Acid Reflux and Microaspiration
Gastroesophageal reflux disease (GERD) is remarkably common in people with IPF, and growing evidence suggests it’s more than a coincidence. The proposed mechanism involves microaspiration: tiny amounts of stomach acid and bile repeatedly reaching the lungs. Studies in mice have shown that gastric contents in the lungs can directly trigger fibrosis, causing thickening of the air sac walls, collagen deposition, and activation of fibrosis-promoting growth factors. In human studies, pepsin and acid are frequently found in fluid washed from the lungs of IPF patients.
The relationship may also be a vicious cycle. As the lungs stiffen, the increased effort of breathing creates more negative pressure in the chest, which can weaken the valve at the top of the esophagus and make reflux worse. More reflux means more microaspiration, which means more lung injury, which means more stiffening.
The Lung Microbiome
The bacterial community living in the lungs appears to influence how quickly IPF progresses. A prospective study found that higher-than-normal levels of specific Streptococcus and Staphylococcus species in the lungs were strongly associated with disease worsening. Patients whose lungs harbored Streptococcus above a certain threshold had roughly 10 times the risk of disease progression, while elevated Staphylococcus levels were associated with about 5 times the risk. Whether these bacteria actively drive scarring or simply thrive in already-damaged lungs is still being sorted out, but their presence appears to be a meaningful marker of how the disease will behave.
Why It’s Never Just One Cause
IPF almost certainly results from multiple hits landing on a vulnerable person. A typical profile might look like this: someone with a genetic variant near MUC5B, decades of low-level dust exposure at work, a long-ago smoking history, a chronic viral infection that never fully cleared, and the natural telomere shortening that comes with aging into your 60s and 70s. No single factor is enough on its own. But layered together, they overwhelm the lung’s repair machinery, tipping it from normal healing into relentless scarring. The reason IPF is still called “idiopathic” isn’t that there are no causes. It’s that the exact combination differs from person to person, and no single trigger can be pointed to as the definitive one.